Clinical Trial Update: Treating PCOS With Semaglutide vs Active Lifestyle Intervention [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial comparing semaglutide to active lifestyle intervention for polycystic ovary syndrome has completed, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: PCOS, Adolescent Obesity | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-11-25